Clinical and immunological characteristics of type 1 diabetes mellitus in a northwestern Colombian population

G. J. Tobon, A. Arango, V. Abad, J. García, H. Cuervo, A. Velásquez, I. D. Angel, P. Vega, A. Abad, J. M. Anaya

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

We underwent a project aimed to define the clinical and immunological characteristics of type 1 diabetes (T1D) in a Colombian population. This was a multicenter and cross-sectional study. Patients were systematically interviewed and their medical records reviewed, using a questionnaire that sought information about demographic, clinical and immunological characteristics. Glutamic acid decarboxylase antibodies (GADA), tyrosine phosphatase antibodies (IA-2A) and insulin antibodies (IAA) were examined by radioimmunoassay. There were 107 patients with T1D. Male:female ratio was 1:1. Half of the patients developed diabetes ketoacidosis at onset. GADA, IA-2A, and IAA were detected in 45%, 40%, and 69% of the cases, respectively. GADA positive patients were older and had a less duration of disease than patients without these autoantibodies (p <0.01). Association between breast feeding with the presence of antibodies or clinical characteristics was not observed. The results highlight some differences of T1D expression according to geographic location and ethnicity. Differences in age at onset and clinical variables may point to an environmental factor or deficient access to health care system. Genetic studies underway will provide important information in this population. These results might help to define public health policies in our population to improve T1D diagnosis, patients' quality of life and their outcome. © 2005 Elsevier Ireland Ltd. All rights reserved.
Original languageEnglish (US)
Pages (from-to)170-175
Number of pages6
JournalDiabetes Research and Clinical Practice
DOIs
StatePublished - May 1 2006

Fingerprint

Type 1 Diabetes Mellitus
Glutamate Decarboxylase
Antibodies
Population
Insulin Antibodies
Geographic Locations
Ketosis
Health Services Accessibility
Public Policy
Health Policy
Breast Feeding
Age of Onset
Phosphoric Monoester Hydrolases
Autoantibodies
Radioimmunoassay
Medical Records
Tyrosine
Public Health
Cross-Sectional Studies
Quality of Life

Cite this

Tobon, G. J. ; Arango, A. ; Abad, V. ; García, J. ; Cuervo, H. ; Velásquez, A. ; Angel, I. D. ; Vega, P. ; Abad, A. ; Anaya, J. M. / Clinical and immunological characteristics of type 1 diabetes mellitus in a northwestern Colombian population. In: Diabetes Research and Clinical Practice. 2006 ; pp. 170-175.
@article{604290afaf534636b315067372ecc525,
title = "Clinical and immunological characteristics of type 1 diabetes mellitus in a northwestern Colombian population",
abstract = "We underwent a project aimed to define the clinical and immunological characteristics of type 1 diabetes (T1D) in a Colombian population. This was a multicenter and cross-sectional study. Patients were systematically interviewed and their medical records reviewed, using a questionnaire that sought information about demographic, clinical and immunological characteristics. Glutamic acid decarboxylase antibodies (GADA), tyrosine phosphatase antibodies (IA-2A) and insulin antibodies (IAA) were examined by radioimmunoassay. There were 107 patients with T1D. Male:female ratio was 1:1. Half of the patients developed diabetes ketoacidosis at onset. GADA, IA-2A, and IAA were detected in 45{\%}, 40{\%}, and 69{\%} of the cases, respectively. GADA positive patients were older and had a less duration of disease than patients without these autoantibodies (p <0.01). Association between breast feeding with the presence of antibodies or clinical characteristics was not observed. The results highlight some differences of T1D expression according to geographic location and ethnicity. Differences in age at onset and clinical variables may point to an environmental factor or deficient access to health care system. Genetic studies underway will provide important information in this population. These results might help to define public health policies in our population to improve T1D diagnosis, patients' quality of life and their outcome. {\circledC} 2005 Elsevier Ireland Ltd. All rights reserved.",
author = "Tobon, {G. J.} and A. Arango and V. Abad and J. Garc{\'i}a and H. Cuervo and A. Vel{\'a}squez and Angel, {I. D.} and P. Vega and A. Abad and Anaya, {J. M.}",
year = "2006",
month = "5",
day = "1",
doi = "10.1016/j.diabres.2005.10.016",
language = "English (US)",
pages = "170--175",
journal = "Diabetes Research and Clinical Practice",
issn = "0168-8227",
publisher = "Elsevier Ireland Ltd",

}

Clinical and immunological characteristics of type 1 diabetes mellitus in a northwestern Colombian population. / Tobon, G. J.; Arango, A.; Abad, V.; García, J.; Cuervo, H.; Velásquez, A.; Angel, I. D.; Vega, P.; Abad, A.; Anaya, J. M.

In: Diabetes Research and Clinical Practice, 01.05.2006, p. 170-175.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Clinical and immunological characteristics of type 1 diabetes mellitus in a northwestern Colombian population

AU - Tobon, G. J.

AU - Arango, A.

AU - Abad, V.

AU - García, J.

AU - Cuervo, H.

AU - Velásquez, A.

AU - Angel, I. D.

AU - Vega, P.

AU - Abad, A.

AU - Anaya, J. M.

PY - 2006/5/1

Y1 - 2006/5/1

N2 - We underwent a project aimed to define the clinical and immunological characteristics of type 1 diabetes (T1D) in a Colombian population. This was a multicenter and cross-sectional study. Patients were systematically interviewed and their medical records reviewed, using a questionnaire that sought information about demographic, clinical and immunological characteristics. Glutamic acid decarboxylase antibodies (GADA), tyrosine phosphatase antibodies (IA-2A) and insulin antibodies (IAA) were examined by radioimmunoassay. There were 107 patients with T1D. Male:female ratio was 1:1. Half of the patients developed diabetes ketoacidosis at onset. GADA, IA-2A, and IAA were detected in 45%, 40%, and 69% of the cases, respectively. GADA positive patients were older and had a less duration of disease than patients without these autoantibodies (p <0.01). Association between breast feeding with the presence of antibodies or clinical characteristics was not observed. The results highlight some differences of T1D expression according to geographic location and ethnicity. Differences in age at onset and clinical variables may point to an environmental factor or deficient access to health care system. Genetic studies underway will provide important information in this population. These results might help to define public health policies in our population to improve T1D diagnosis, patients' quality of life and their outcome. © 2005 Elsevier Ireland Ltd. All rights reserved.

AB - We underwent a project aimed to define the clinical and immunological characteristics of type 1 diabetes (T1D) in a Colombian population. This was a multicenter and cross-sectional study. Patients were systematically interviewed and their medical records reviewed, using a questionnaire that sought information about demographic, clinical and immunological characteristics. Glutamic acid decarboxylase antibodies (GADA), tyrosine phosphatase antibodies (IA-2A) and insulin antibodies (IAA) were examined by radioimmunoassay. There were 107 patients with T1D. Male:female ratio was 1:1. Half of the patients developed diabetes ketoacidosis at onset. GADA, IA-2A, and IAA were detected in 45%, 40%, and 69% of the cases, respectively. GADA positive patients were older and had a less duration of disease than patients without these autoantibodies (p <0.01). Association between breast feeding with the presence of antibodies or clinical characteristics was not observed. The results highlight some differences of T1D expression according to geographic location and ethnicity. Differences in age at onset and clinical variables may point to an environmental factor or deficient access to health care system. Genetic studies underway will provide important information in this population. These results might help to define public health policies in our population to improve T1D diagnosis, patients' quality of life and their outcome. © 2005 Elsevier Ireland Ltd. All rights reserved.

U2 - 10.1016/j.diabres.2005.10.016

DO - 10.1016/j.diabres.2005.10.016

M3 - Article

C2 - 16325957

SP - 170

EP - 175

JO - Diabetes Research and Clinical Practice

JF - Diabetes Research and Clinical Practice

SN - 0168-8227

ER -